These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1145 related articles for article (PubMed ID: 9491822)

  • 21. Metabolism of 7-benzyloxy-4-trifluoromethyl-coumarin by human hepatic cytochrome P450 isoforms.
    Renwick AB; Surry D; Price RJ; Lake BG; Evans DC
    Xenobiotica; 2000 Oct; 30(10):955-69. PubMed ID: 11315104
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of cytochrome P450 3A4 in human metabolism of MK-639, a potent human immunodeficiency virus protease inhibitor.
    Chiba M; Hensleigh M; Nishime JA; Balani SK; Lin JH
    Drug Metab Dispos; 1996 Mar; 24(3):307-14. PubMed ID: 8820421
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of the human cytochrome P450 enzymes involved in the in vitro biotransformation of lynestrenol and norethindrone.
    Korhonen T; Turpeinen M; Tolonen A; Laine K; Pelkonen O
    J Steroid Biochem Mol Biol; 2008 May; 110(1-2):56-66. PubMed ID: 18356043
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential inhibition of cytochrome P450 isoforms by the protease inhibitors, ritonavir, saquinavir and indinavir.
    Eagling VA; Back DJ; Barry MG
    Br J Clin Pharmacol; 1997 Aug; 44(2):190-4. PubMed ID: 9278209
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of the human and rat P450 enzymes responsible for the sulfoxidation of S-methyl N,N-diethylthiolcarbamate (DETC-ME). The terminal step in the bioactivation of disulfiram.
    Madan A; Parkinson A; Faiman MD
    Drug Metab Dispos; 1995 Oct; 23(10):1153-62. PubMed ID: 8654205
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of human CYP1A2 activity in vitro by methylxanthines: potent competitive inhibition by 8-phenyltheophylline.
    Murray S; Odupitan AO; Murray BP; Boobis AR; Edwards RJ
    Xenobiotica; 2001 Mar; 31(3):135-51. PubMed ID: 11465391
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of human cytochrome P450 isoforms involved in the 3-hydroxylation of quinine by human live microsomes and nine recombinant human cytochromes P450.
    Zhao XJ; Yokoyama H; Chiba K; Wanwimolruk S; Ishizaki T
    J Pharmacol Exp Ther; 1996 Dec; 279(3):1327-34. PubMed ID: 8968357
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of the cytochrome P450 isoenzymes involved in the in vitro N-dealkylation of haloperidol.
    Pan LP; Wijnant P; De Vriendt C; Rosseel MT; Belpaire FM
    Br J Clin Pharmacol; 1997 Dec; 44(6):557-64. PubMed ID: 9431831
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Kinetic characterization and identification of the enzymes responsible for the hepatic biotransformation of adinazolam and N-desmethyladinazolam in man.
    Venkatakrishnan K; von Moltke LL; Duan SX; Fleishaker JC; Shader RI; Greenblatt DJ
    J Pharm Pharmacol; 1998 Mar; 50(3):265-74. PubMed ID: 9600717
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro inhibitory effect of 1-aminobenzotriazole on drug oxidations in human liver microsomes: a comparison with SKF-525A.
    Emoto C; Murase S; Sawada Y; Iwasaki K
    Drug Metab Pharmacokinet; 2005 Oct; 20(5):351-7. PubMed ID: 16272753
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The xenobiotic inhibitor profile of cytochrome P4502C8.
    Ong CE; Coulter S; Birkett DJ; Bhasker CR; Miners JO
    Br J Clin Pharmacol; 2000 Dec; 50(6):573-80. PubMed ID: 11136296
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of human cytochrome P450 isoforms involved in the metabolism of S-2-[4-(3-methyl-2-thienyl)phenyl]propionic acid.
    Taguchi K; Konishi T; Nishikawa H; Kitamura S
    Xenobiotica; 1999 Sep; 29(9):899-907. PubMed ID: 10548450
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metabolism of human cytochrome P450 marker substrates in mouse: a strain and gender comparison.
    Löfgren S; Hagbjörk AL; Ekman S; Fransson-Steen R; Terelius Y
    Xenobiotica; 2004 Sep; 34(9):811-34. PubMed ID: 15742976
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of human cytochrome P450 enzymes by 1,4-dihydropyridine calcium antagonists: prediction of in vivo drug-drug interactions.
    Katoh M; Nakajima M; Shimada N; Yamazaki H; Yokoi T
    Eur J Clin Pharmacol; 2000; 55(11-12):843-52. PubMed ID: 10805063
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of cytochrome P450 enzymes involved in the metabolism of zotepine, an antipsychotic drug, in human liver microsomes.
    Shiraga T; Kaneko H; Iwasaki K; Tozuka Z; Suzuki A; Hata T
    Xenobiotica; 1999 Mar; 29(3):217-29. PubMed ID: 10219963
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chlorzoxazone is metabolized by human CYP1A2 as well as by human CYP2E1.
    Ono S; Hatanaka T; Hotta H; Tsutsui M; Satoh T; Gonzalez FJ
    Pharmacogenetics; 1995 Jun; 5(3):143-50. PubMed ID: 7550365
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of CYP3A4 in human hepatic diltiazem N-demethylation: inhibition of CYP3A4 activity by oxidized diltiazem metabolites.
    Sutton D; Butler AM; Nadin L; Murray M
    J Pharmacol Exp Ther; 1997 Jul; 282(1):294-300. PubMed ID: 9223567
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fondaparinux sodium is not metabolised in mammalian liver fractions and does not inhibit cytochrome P450-mediated metabolism of concomitant drugs.
    Lieu C; Shi J; Donat F; Van Horn R; Brian W; Newton J; Delbressine L; Vos R
    Clin Pharmacokinet; 2002; 41 Suppl 2():19-26. PubMed ID: 12383041
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lauric acid as a model substrate for the simultaneous determination of cytochrome P450 2E1 and 4A in hepatic microsomes.
    Clarke SE; Baldwin SJ; Bloomer JC; Ayrton AD; Sozio RS; Chenery RJ
    Chem Res Toxicol; 1994; 7(6):836-42. PubMed ID: 7696540
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Polysaccharide peptides from COV-1 strain of Coriolus versicolor inhibit tolbutamide 4-hydroxylation in the rat in vitro and in vivo.
    Yeung JH; Chan SL; Or PM
    Food Chem Toxicol; 2006 Aug; 44(8):1414-23. PubMed ID: 16698161
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 58.